Publication:
MIA - a new target protein for malignant melanoma therapy

Simple item page
dc.contributor.authorSchmidt, Jennifer
dc.contributor.authorRiechers, Alexander
dc.contributor.authorBosserhoff, Anja-Katrin
dc.date.accessioned2018-03-08T18:17:17Z
dc.date.available2018-03-08T18:17:17Z
dc.date.issued2013
dc.description.abstractMalignant melanoma, a malignancy of pigment producing cells, causes the greatest number of skin cancer-related deaths worldwide. The tumor is characterized by its aggressive phenotype and can metastasize at very early stages of the disease. Since metastatic lesions are usually characterized by an intrinsic resistance to standard radiation and chemotherapy, the prognosis of this tumor remains very poor in advanced stages. Melanoma inhibitory activity (MIA), an 11 kDa protein expressed and secreted by melanoma cells after their malignant transformation, is known to play a key role in melanoma development, progression and tumor cell invasion. After its secretion, which is restricted to the rear pole of migrating cells, MIA protein directly interacts with cell adhesion receptors and extracellular matrix molecules. By this mechanism, MIA protein actively facilitates focal cell detachment from surrounding structures at the cell rear and strongly promotes tumor cell invasion and formation of metastases. It has further been demonstrated that MIA contributes to immunosuppression frequently seen in malignant melanomas by binding to integrin α4ß1 expressed by leukocytes and thus inhibiting cellular antitumor immune response. Analyses at the molecular level revealed that MIA protein reaches functional activity by self assembly. Functional inactivation of MIA protein by dodecapeptides that directly bind to the dimerization interface leads to a strongly reduced tumor cell invasion in an in vivo mouse melanoma model. The molecular understanding of the contribution of MIA protein to formation of metastases provides an excellent starting point for the development of a new strategy in malignant melanoma therapy.en_EN
dc.formatapplication/pdfes
dc.format.extent6es
dc.identifier.citationHistology and histopathology, Vol. 28, n.º 4 (2013)
dc.identifier.issn1699-5848
dc.identifier.issn0213-3911
dc.identifier.urihttp://hdl.handle.net/10201/57102
dc.languageenges
dc.publisherF. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de Biología Celular e Histologíaes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectMIAes
dc.subjectMalignant melanomaes
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleMIA - a new target protein for malignant melanoma therapyen_EN
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Schmidt-28-421-426-2013.pdf
Size:
2.33 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.39 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Histology and histopathology Vol.28, nº 4 (2013)